1Safety and efficacy of recombinant human endostatin (Endostar (R)) in combination with platinum-based doublet chemotherapy for the treatment of advanced non-small cell lung cancer: a national wide, open,multi-center, and phase Ⅳ clinical studyEndostar Phase Ⅳ Study GroupARTICLES289-2982Effect of microRNA-1297 on invasion/migration and Notch/zeb1 signaling pathway of gastric cancer cellsZHANG Renmin, FAN Qingyu, LI Zhongyou, PENG Wei, ZHONG Yuejiao, ZHOU Zhaofei, LU JianweiARTICLES299-3033Expression and clinical significance of PDCD1 in nasopharyngeal carcinoma tissuesQU Huiwen, JIN Jianping, CHANG TaoARTICLES304-3094Diagnostic value of plasma levels of microRNA-21 and microRNA-25 in esophageal squamous cell carcinomaLIU Xin, LI Qianwen, WEN Xuyang, LIU Feng, ZHANG Zuoyan, LI JianfeiARTICLES310-3135Expression and clinical significance of long non-coding RNA TUG1 in breast cancer tissuesXU Wenting, LIU Tingting, WU Tao, YANG Liang, LI Dan, LI Shuangjian, DILIXIATI Jinsihan, ZHAO QianARTICLES314-3196Expression and clinical significance of microRNA-34b in non-small cell lung cancer tissuesXU Yan, WU LijuanARTICLES320-3237Analysis of the relationship between thrombocytosis and clinicopathological features in patients with non-small cell lung cancerSHEN Kaikai, LV TangfengARTICLES324-3288Clinical significance and expression of HOXA7 and HOXC8 in gastric carcinoma tissuesXU Dongyun, XU Yongmao, LI Ke, ZHANG Yahui, YU Guanzhen, WANG JiejunARTICLES329-3339Clinical significance and level of microRNA-449b in colorectal cancer tissuesZHANG Daoquan, JIN Shu, ZHOU YubaoARTICLES334-33710Analysis of the relationship between polymorphisms of NME1 and susceptibility of non-small cell lung cancerMENG Fanliang, HU Jiegui, CHEN Yaxin, GUO TaipingARTICLES338-34311Clinical significance and level of microRNA-29c in cervical cancer tissuesJIANG Lisa, LU Yihong, FU Liutao, WANG Wenyan, WEI BingARTICLES344-34812Analysis of factors influencing recurrence of primary sacral chordoma after surgical treatmentYANG Yongkun, ZHANG Qing, HAO Lin, LI Yuan, XU Hairong, LIU Weifeng, NIU XiaohuiARTICLES349-35313Clinical application of nano carbon suspension in sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancerWEI Na, DAI Min, DU Kuiying, WANG Shu, HOU Jing, NI QingARTICLES354-35814Efficacy and safety of bevacizumab combined with regimen of pemetrexed/cisplatin as the first-line therapy for advanced lung adenocarcinoma patients with EGFR wild-typeZHANG Qian, WANG Wei, XU ChunhuaCLINICAL PRACTICE359-36315Progression in immunotherapy for advanced pancreatic cancerSONG Wei, JIANG Man, ZHANG XiaochunREVIEW AND LECTURES364-36816Research progression on the inhibitory effect of metformin on prostate cancerXIAO Zhaoming, HAN Yuefu, ZHAO ShanchaoREVIEW AND LECTURES369-37417Current status of clinical research on antiangiogenic therapeutic drugs for hepatocellular carcinomaZHANG Qiong, ZHANG Jing, YU Zhicao, WANG Xiangxu, ZHANG HongmeiREVIEW AND LECTURES375-381 